SCHEMBL19984712

SCHEMBL19984712

CC(O)C(C(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.59
CES2 O00748 1/20 0.59
CES1 P23141 1/20 0.59
ALDH1A1 P00352 5/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
NPSR1 Q6W5P4 1/20 0.56
TDP1 Q9NUW8 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
CYP2D6 P10635 1/20 0.50
CYP3A4 P08684 3/20 0.49
KMT2A Q03164 1/20 0.47
KDM4E B2RXH2 2/20 0.46
PGR P06401 1/20 0.46
ADRA2A P08913 1/20 0.46
ADRA2B P18089 1/20 0.46
HTR2A P28223 1/20 0.46
HRH1 P35367 1/20 0.46
KCNH2 Q12809 1/20 0.46
MAPK1 P28482 2/20 0.43
MAPT P10636 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31478208 0.88 LMNA (0.54) LMNACES2CES1ALDH1A1SMN1; SMN2
SCHEMBL31478257 0.88 CES2 (0.47) LMNACES2CES1ALDH1A1SMN1; SMN2
SCHEMBL3092001 0.86 LMNA (0.57) LMNACES2CES1ALDH1A1SMN1; SMN2
SCHEMBL28830240 0.85 LMNA (0.65) LMNACES2CES1ALDH1A1SMN1; SMN2
SCHEMBL29110135 0.84 LMNA (0.70) LMNACES2CES1ALDH1A1SMN1; SMN2
SCHEMBL27484428 0.82 LMNA (0.58) LMNACES2CES1ALDH1A1SMN1; SMN2
SCHEMBL23903947 0.81 CYP2D6 (0.70) LMNACES2CES1ALDH1A1CYP2D6
SCHEMBL20511280 0.81 CYP2D6 (0.70) LMNACES2CES1ALDH1A1CYP2D6
SCHEMBL11822535 0.81 CYP2D6 (0.70) LMNACES2CES1ALDH1A1CYP2D6
SCHEMBL20511263 0.81 CYP2D6 (0.70) LMNACES2CES1ALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2306986-B1 PRODRUGS AND DRUG-MACROMOLECULE CONJUGATES HAVING CONTROLLED DRUG RELEASE RATES PROLYNX LLC (US) 2018-03-21 EP disclosed